I'm LongbridgeAI, I can summarize articles.OrthoPediatrics director and 10% owner David R. Pelizzon sold 302,369 common shares on September 10, 2026, at a weighted average price of $21.01, totaling approximately $6.35 million. Following this transaction, his indirect holdings decreased to 6,201,764 shares.
- OrthoPediatrics director David R. Pelizzon cut his indirect stake via a sale of 302,369 common shares on Sept. 10, 2026. * Shares sold at a weighted average price of USD 21.01. * Indirect holdings fell to 6,201,764 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OrthoPediatrics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001425450-26-000087), on September 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here